Overview

A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure

Status:
Completed
Trial end date:
2017-11-27
Target enrollment:
Participant gender:
Summary
This is a phase 2 randomized, double-blind, placebo-controlled study to evaluate the cardiac and renal effects of short term treatment with elamipretide in patients hospitalized with congestion due to heart failure
Phase:
Phase 2
Details
Lead Sponsor:
Stealth BioTherapeutics Inc.